There is a lot of stigma around psychedelics.
Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.
Topics in this episode
0:00 Intro
1:07 Founding EYWA
3:53 Advice for Startup Founders in LATAM
8:51 What is Biosynthesis?
12:34 What Molecules is EYWA Focusing On?
13:35 How to Show Commercial Traction Before Regulatory Approval?
15:03 The Psychedelics Ecosystem
16:26 Scientific Data About Psychedelics
23:51 What is EYWA's Business Model?
25:49 How Does IP Shape an R&D Roadmap?
27:56 Why Use AI and Bioinformatics?
33:27 Regulatory Landscape for Psychedelics
40:14 The Investors' Perception of Psychedelics
44:17 EYWA's Most Recent Funding Round
46:14 Building Relationships with Investors
51:02 EYWA's Fundraising Plans
51:37 Recording a TV Show with Tim and Adam Draper
53:43 What's Next for EYWA
Connect with Vicky on LinkedIn https://www.linkedin.com/in/victoria-costa-paz-a83499b2/
Follow EYWA on LinkedIn https://www.linkedin.com/company/eywabio/posts/?feedView=all
Follow EYWA on Instagram https://www.instagram.com/eywa.bio/
Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/
Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc
Follow Science VC on Instagram https://www.instagram.com/science.vc
Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC
Subscribe to our Newsletter https://substack.com/@jporlov
Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/